|Articles|April 13, 2003
Alcon symposium provides surgical perspectives, drug therapies
San Francisco-More than 1,000 guests filled the Davies Symphony Hallon Sunday evening to listen to current ophthalmic developments in a symposiumentitled "Surgical Perspective and Drug Therapies: Cataract, Refractive,and Glaucoma."
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy
2
Alcon raises offer in amended deal to acquire STAAR Surgical
3
Ocular Therapeutix accelerates NDA submission plans for AXPAXLI for wet AMD
4
Study maps thermal dynamics of glaucoma laser treatments
5










































.png)


